Wang, Lu
Ma, Xudong
Zhou, Guanghua
Gao, Sifa
Pan, Wei
Chen, Jieqing
Su, Longxiang
He, Huaiwu
Long, Yun
Yin, Zhi
Shu, Ting
Zhou, Xiang
,
Liu, Yongjun
Kang, Yan
Yan, Jing
Chen, Erzhen
Xiong, Bin
Qin, Bingyu
Qian, Kejian
Fang, Wei
Zhao, Mingyan
Ma, Xiaochun
Yu, Xiangyou
Lin, Jiandong
Yang, Yi
Shen, Feng
Li, Shusheng
Zhang, Lina
Wu, Weidong
Duan, Meili
Wan, Linjun
Yang, Xiaojun
Liu, Jian
Wang, Zhen
Xu, Lei
Hu, Zhenjie
Yang, Congshan
Funding for this research was provided by:
National Natural China (81801901)
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-115, 2022-PUMCH-B-115)
National Key Research and Development Program of China (2020YFC0861000)
China Medical Board (CMB 20-381)
Article History
Received: 9 February 2024
Accepted: 18 April 2024
First Online: 24 May 2024
Declarations
:
: The trial protocol was approved by the Central Institutional Review Board at Peking Union Medical College Hospital (NO. SK1828) and individual consent for this retrospective analysis was waived.
: All authors have agreed to publish it.
: The authors declare that they have no competing interests. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.